Van Berkom & Associates Inc. lessened its position in Maximus, Inc. (NYSE:MMS – Free Report) by 87.8% during the 3rd quarter, HoldingsChannel.com reports. The fund owned 132,403 shares of the health services provider’s stock after selling 955,643 shares during the quarter. Van Berkom & Associates Inc.’s holdings in Maximus were worth $7,043,000 at the end of the most recent reporting period.
A number of other institutional investors have also recently made changes to their positions in the company. Leuthold Group LLC purchased a new stake in shares of Maximus during the third quarter worth approximately $304,000. Fulcrum Asset Management LLP acquired a new position in Maximus in the 3rd quarter valued at $179,000. CenterBook Partners LP purchased a new position in Maximus in the 3rd quarter valued at $256,000. Chicago Partners Investment Group LLC purchased a new position in Maximus in the 3rd quarter valued at $337,000. Finally, Covestor Ltd lifted its holdings in Maximus by 33.2% in the 3rd quarter. Covestor Ltd now owns 2,199 shares of the health services provider’s stock valued at $117,000 after purchasing an additional 548 shares in the last quarter. 97.21% of the stock is owned by institutional investors and hedge funds.
Maximus Stock Down 0.2%
Shares of MMS opened at $65.39 on Tuesday. The company’s 50-day simple moving average is $58.87 and its 200-day simple moving average is $64.22. The company has a debt-to-equity ratio of 0.90, a quick ratio of 2.42 and a current ratio of 2.42. Maximus, Inc. has a 1 year low of $51.04 and a 1 year high of $100.00. The stock has a market capitalization of $3.42 billion, a PE ratio of 9.66 and a beta of 0.57.
Maximus Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Monday, November 30th. Shareholders of record on Friday, November 13th will be issued a dividend of $0.33 per share. The ex-dividend date is Friday, November 13th. This represents a $1.32 dividend on an annualized basis and a yield of 2.0%. Maximus’s dividend payout ratio is 19.50%.
Analysts Set New Price Targets
Several equities research analysts have issued reports on the stock. Zacks Research raised shares of Maximus from a “strong sell” rating to a “hold” rating in a research note on Thursday, October 1st. Wall Street Zen cut shares of Maximus from a “buy” rating to a “hold” rating in a research report on Saturday, August 8th. Finally, Weiss Ratings reissued a “hold (c-)” rating on shares of Maximus in a research note on Monday, August 17th. Two research analysts have rated the stock with a Hold rating. Based on data from MarketBeat, the company currently has an average rating of “Hold”.
Read Our Latest Stock Analysis on MMS
Insider Transactions at Maximus
In other Maximus news, insider Michelle Link sold 3,208 shares of the firm’s stock in a transaction that occurred on Thursday, October 1st. The shares were sold at an average price of $54.23, for a total value of $173,969.84. Following the completion of the transaction, the insider owned 13,881 shares of the company’s stock, valued at $752,766.63. This trade represents a 18.77% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. 1.80% of the stock is currently owned by company insiders.
Maximus Company Profile
Further Reading
- Five stocks we like better than Maximus
- Wall Street May Be Making a Big Mistake With monday.com Stock
- Are These 2 Mid-Cap Growth Stocks Worth the Risk?
- Oklo Changes the Narrative: Does a Nuclear Stock Price Explosion Come Next?
- Cloudflare’s 20% Sell-Off May Have Created an Opening for Investors
Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Maximus, Inc. (NYSE:MMS – Free Report).
Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.
